A Study on Mass-Screening Test for Detection of Bladder Cancer by Automated Urine Cytology
A Study on Mass-Screening Test for Detection of Bladder Cancer by Automated Urine Cytology
批准号:
01570907
负责人:
TACHIBANA Masaaki
金额:
$0.45万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1989
资助国家:
日本
项目状态:
已结题
起止时间:
1989 至 1990
中文摘要
点击翻译按钮获取中文摘要
英文摘要
A direct correlation clearly exists between the presence of abnormal deoxyribonucleic acid (DNA) contents within the tumors and the degree of clinical malignancy in several tumor system. The modern flow cytometric technique can measure DNA in complex cell mixtures via individual cell examination at the tremendous rate. Therefore, this analysis can be uterized quantitative and objective detection of malignant cells in urine sample which can be applied to automated urine cytology. In order to evaluate flow cytometric DNA measurement (FCM) of bladder washing in the diagnosis of bladder cancer, the sensitivity of voided urine cytology, bladder washing cytology and bladder washing FCM was tested. The results from 76 samples from 56 patients with histologically proven transitional cell carcinoma of the bladder, FCM is more sensitive than voided urine cytology and/or bladder washing cytology. Also was found that FCM may indicate urothelial neoplasia before it is apparent on urine cytology, es … More pecially against a background of inflammation. Therefore, FCM is thought to be valuable for case finding in suspected population or for follow-up cases with diagnosed bladder cancer. However, potential developments of, and further improvements is needed since the sensitivity for detecting low-grade-tumor was low. In this regard, flow cytometric DNA/bromodeoxyuridine (BrdU) bivariate analysis was performed whether the technique can provide further information on the malignant potential of bladder cancer than DNA analysis alone. Results from a total of 56 bladder tumors, DNA/BrdU two-color FCM can provide an objective parameter for quantification of the malignant potential of bladder cancers. Thus, FCM technique is advantageous than classical cytology because of ; 1) higher sensitivity, 2) early predictability and 3) more objective and quantitative analysis. Meanwhile, malignant tumor cell detection by computer-assisted image analysis was performed. So far, the method can differentiate white blood cell, red blood cell, epithelial cell and crystals. Also, high-grade tumor cell can be identified because of high-nuclear/cell ration. However, difficulty of clarification on low-grade tumor cell were found. This result indicate that further identification of tumor-specific markers are needed for improvement of this method as routine laboratory procedures. Less
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
橘 政昭: "泌尿器系腫瘍におけるフローサイトメトリーによるDNA ploidy解析の意義" 慶應医学. (1991)
Masaaki Tachibana:“通过流式细胞术进行 DNA 倍体分析在泌尿系统肿瘤中的意义”Keio Medicine (1991)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Masaaki Tachibana,et al: "Quantification of cell kinetic characteristics using flow cytometric measurements of deoxyribonucleic acid and bromodeoxyuridine for bladder cancer" J.Urol. (1991)
Masaaki Tachibana 等人:“使用流式细胞术测量膀胱癌的脱氧核糖核酸和溴脱氧尿苷来量化细胞动力学特征”J.Urol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Masaaki Tachibana and Hiroshi Tazaki: "Clinical application of flow cytometric deoxyribonucleic acid Ploidy analysis in urological cancer" Proceedings of the international symposium on flow cytometry and image analysis for clinical application.(1991)
Masaaki Tachibana 和 Hiroshi Tazaki:“流式细胞术脱氧核糖核酸倍性分析在泌尿系统癌症中的临床应用”流式细胞术和图像分析临床应用国际研讨会论文集。(1991)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Masaaki Tachibana, Seido jitsukawa and Hiroshi Tazaki: "A comparative study of the sensitivity of bladder washing flow cytometry, voided urine cytology and bladder washing cytology in the detection of bladder carcinoma" Japanese Journal of Urology. 80. 10
Masaaki Tachibana、Seido jitsukawa 和 Hiroshi Tazaki:“膀胱冲洗流式细胞术、排泄尿细胞学和膀胱冲洗细胞学检测膀胱癌敏感性的比较研究”日本泌尿学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
橘 政昭 他: "膀胱癌診断における flow cytometric DNA histogram,自然尿細胞診,膀胱洗浄液細胞診の比較検討" 日本泌尿器科学会雑誌. 80. 1025-1030 (1989)
Masaaki Tachibana 等人:“流式细胞术 DNA 直方图、自然尿细胞学和膀胱灌洗液细胞学诊断膀胱癌的比较研究”日本泌尿外科协会杂志 80. 1025-1030 (1989)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 13 条
Tumor specific immunotherapy using dendritic cells generated from allogeneic peripheral stem cell.
-
批准号:14370520
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.22万
-
财政年份:2002
-
负责人:TACHIBANA Masaaki
-
依托单位:
HLA restricted tumor specific antigen epitope pulsed autologous dendritic cell vaccine treatment for hormone refractory prostate cancer
-
批准号:12671557
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.56万
-
财政年份:2000
-
负责人:TACHIBANA Masaaki
-
依托单位:
Induction of apoptosis against cytokine-producing urological cancer
-
批准号:10671493
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.11万
-
财政年份:1998
-
负责人:TACHIBANA Masaaki
-
依托单位:
Establish mentofthe minimally invasive treatments based on biological characteristics for advanceduro logical cancers.
-
批准号:07407046
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$14.21万
-
财政年份:1995
-
负责人:TACHIBANA Masaaki
-
依托单位:
Studies on objective indicator for predicting malignant potential of bladder cancer.
-
批准号:04454409
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.9万
-
财政年份:1992
-
负责人:TACHIBANA Masaaki
-
依托单位:
海外基金